Skip to main content
Clinical Trials/NL-OMON30524
NL-OMON30524
Recruiting
Not Applicable

Monitoring the microcirculation of patients with advanced lungcancer treated with bevacizumab and chemotherapy using optical spectroscopy. - DPS, Lungcancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
lungcancer
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
20
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • · suspected endoscopically visible tumour
  • · written informed consent
  • · histologycally or cytologicoly documented inoperable advanged stage IV NSCLC or extensive SCLC
  • · Life expectancy \> 12weeks
  • · Adequate hemologycal/liver/renal function
  • · INR\< 1,5
  • · In case of female, not pregnant or breastfeeding

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials